Fractional Flow Reserve Market Insights, Emerging Trends, Growth and Forecasts, 2016-2020

Submitted by: Submitted by

Views: 10

Words: 1062

Pages: 5

Category: Business and Industry

Date Submitted: 07/11/2016 03:01 AM

Report This Essay

Summary

Technavio Announces the Publication of its Research Report – Global Fractional Flow Reserve Market 2016-2020

Technavio recognizes the following companies as the key players in the global fractional flow reserve market: ACIST, Boston Scientific, Opsens, St. Jude Medical, Volcano.

Other Prominent Vendors in the market are: Abbott Laboratories, Asahi Intec, Biosensors, BIOTRONIK international, GE Healthcare, HeartFlow, McKesson, Mennen Medical, Siemens Healthcare, and Terumo.

Commenting on the report, an analyst from Technavio’s team said: “A trend which is propelling market growth is the rising number of clinical trials and regulatory approvals. There has been a growing trend of clinical trials and regulatory approvals in the market. With the growing demand for fractional flow reserve technology, the new companies are continuously seeking ways to gain approvals and launch new products in the market to improve their market share. In January 2014, ACIST's RXi received 510(k) FDA approval for use in gaining intravascular pressure measurements in the diagnosis and treatment of peripheral artery disease and CAD.”

Browse Detail Report With TOC @

https://marketreportscenter.com/reports/316911/global-fractional-flow-reserve-market-2016-2020

According to the report, a key growth driver is the increased need for diagnosis of coronary artery diseases (CAD). There has been an increased need for a suitable procedure to diagnose the growing prevalence of CAD. Coronary angiography is the standard procedure used for diagnosis of CAD. However, the standard coronary angiography with visual assessment and quantitative coronary angiography alone cannot accurately predict the exact lesion that is causing ischemia. These methods may not provide the clear picture about the severity and hemodynamic significance of lesions. Several studies state that the coronary angiogram is limited and does not measure the extent to which a stenosis is hampering the blood flow....